Many studies have demonstrated the anti-oncogenic and anti-metastatic activities of N-myc downstream-regulated gene 1 (NDRG1) in a variety of aggressive solid tumors, including pancreatic cancer, breast cancer, colon cancer, and prostate cancer (1, 2, 3, 4). This evidence concerns the gene NDRG1 and malignant colon neoplasm.